annual current liabilities:
$27.87B-$2.68B(-8.76%)Summary
- As of today (May 29, 2025), AZN annual total current liabilities is $27.87 billion, with the most recent change of -$2.68 billion (-8.76%) on December 31, 2024.
- During the last 3 years, AZN annual current liabilities has risen by +$5.27 billion (+23.33%).
- AZN annual current liabilities is now -8.76% below its all-time high of $30.54 billion, reached on December 31, 2023.
Performance
AZN Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$29.13B(NaN%)Summary
- As of today (May 29, 2025), AZN quarterly total current liabilities is $29.13 billion
- Over the past year, AZN quarterly current liabilities has increased by +$228.00 million (+0.79%).
- AZN quarterly current liabilities is now at all-time high.
Performance
AZN quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
AZN Current liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -8.8% | +0.8% |
3 y3 years | +23.3% | +28.1% |
5 y5 years | +53.8% | +70.9% |
AZN Current liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -8.8% | +23.3% | at high | +33.5% |
5 y | 5-year | -8.8% | +53.8% | at high | +70.9% |
alltime | all time | -8.8% | +1623.9% | at high | +882.7% |
AZN Current liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $29.13B(+12.4%) |
Dec 2024 | $27.87B(-8.8%) | - |
Sep 2024 | - | $25.93B(-9.2%) |
Jun 2024 | - | $28.57B(-1.2%) |
Mar 2024 | - | $28.90B(+1.1%) |
Dec 2023 | $30.54B(+16.2%) | - |
Sep 2023 | - | $28.59B(+8.4%) |
Jun 2023 | - | $26.38B(+6.1%) |
Mar 2023 | - | $24.86B(-5.5%) |
Dec 2022 | $26.29B(+16.4%) | $26.29B(+5.8%) |
Sep 2022 | - | $24.85B(+13.9%) |
Jun 2022 | - | $21.82B(-4.1%) |
Mar 2022 | - | $22.74B(+0.6%) |
Dec 2021 | $22.59B(+11.3%) | $22.59B(-4.5%) |
Sep 2021 | - | $23.65B(+6.4%) |
Jun 2021 | - | $22.22B(+3.3%) |
Mar 2021 | - | $21.51B(+5.9%) |
Dec 2020 | $20.31B(+12.1%) | $20.31B(+7.2%) |
Sep 2020 | - | $18.94B(+4.2%) |
Jun 2020 | - | $18.18B(+6.7%) |
Mar 2020 | - | $17.04B(-5.9%) |
Dec 2019 | $18.12B(+11.2%) | $18.12B(+22.6%) |
Sep 2019 | - | $14.78B(-7.8%) |
Jun 2019 | - | $16.03B(-12.2%) |
Mar 2019 | - | $18.26B(+12.1%) |
Dec 2018 | $16.29B(-0.6%) | $16.29B(+6.8%) |
Sep 2018 | - | $15.25B(-11.4%) |
Jun 2018 | - | $17.20B(-5.3%) |
Mar 2018 | - | $18.16B(+10.9%) |
Dec 2017 | $16.38B(+7.4%) | $16.38B(+13.3%) |
Sep 2017 | - | $14.46B(-7.6%) |
Jun 2017 | - | $15.66B(+1.5%) |
Mar 2017 | - | $15.43B(+1.1%) |
Dec 2016 | $15.26B(+2.6%) | $15.26B(-0.8%) |
Sep 2016 | - | $15.38B(+7.3%) |
Jun 2016 | - | $14.34B(-10.0%) |
Mar 2016 | - | $15.93B(+7.1%) |
Dec 2015 | $14.87B(-14.2%) | $14.87B(-7.3%) |
Sep 2015 | - | $16.04B(-0.7%) |
Jun 2015 | - | $16.15B(+2.5%) |
Mar 2015 | - | $15.76B(-9.1%) |
Dec 2014 | $17.33B(+8.0%) | $17.33B(+9.5%) |
Sep 2014 | - | $15.82B(-3.1%) |
Jun 2014 | - | $16.32B(-6.8%) |
Mar 2014 | - | $17.51B(+9.1%) |
Dec 2013 | $16.05B(+15.4%) | $16.05B(+9.4%) |
Sep 2013 | - | $14.68B(-3.4%) |
Jun 2013 | - | $15.20B(+9.6%) |
Mar 2013 | - | $13.86B(-0.3%) |
Dec 2012 | $13.90B(-11.7%) | $13.90B(-1.6%) |
Sep 2012 | - | $14.13B(-4.5%) |
Jun 2012 | - | $14.80B(-6.3%) |
Mar 2012 | - | $15.80B(+0.3%) |
Dec 2011 | $15.75B(-6.2%) | $15.75B(+7.5%) |
Sep 2011 | - | $14.66B(+5.9%) |
Jun 2011 | - | $13.84B(-13.6%) |
Mar 2011 | - | $16.02B(-4.6%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2010 | $16.79B(-4.8%) | $16.79B(-0.4%) |
Sep 2010 | - | $16.85B(+3.4%) |
Jun 2010 | - | $16.30B(-4.1%) |
Mar 2010 | - | $16.99B(-3.7%) |
Dec 2009 | $17.64B(+31.5%) | $17.64B(+16.7%) |
Sep 2009 | - | $15.12B(-0.2%) |
Jun 2009 | - | $15.14B(+7.8%) |
Mar 2009 | - | $14.05B(+4.7%) |
Dec 2008 | $13.41B(-11.7%) | $13.41B(-7.2%) |
Sep 2008 | - | $14.46B(-9.6%) |
Jun 2008 | - | $15.99B(+2.0%) |
Mar 2008 | - | $15.68B(+3.3%) |
Dec 2007 | $15.19B(+60.8%) | $15.19B(-2.2%) |
Sep 2007 | - | $15.53B(-37.7%) |
Jun 2007 | - | $24.93B(+140.9%) |
Mar 2007 | - | $10.35B(+9.5%) |
Dec 2006 | $9.45B(+38.1%) | $9.45B(+16.8%) |
Sep 2006 | - | $8.09B(-3.8%) |
Jun 2006 | - | $8.40B(-11.0%) |
Mar 2006 | - | $9.45B(+38.1%) |
Dec 2005 | $6.84B(+3.8%) | $6.84B(+1.5%) |
Sep 2005 | - | $6.74B(-0.8%) |
Jun 2005 | - | $6.80B(-0.6%) |
Mar 2005 | - | $6.84B(+3.8%) |
Dec 2004 | $6.59B(-14.4%) | $6.59B(-2.6%) |
Sep 2004 | - | $6.76B(-2.8%) |
Jun 2004 | - | $6.96B(-10.2%) |
Mar 2004 | - | $7.75B(+0.7%) |
Dec 2003 | $7.70B(-6.3%) | $7.70B(+8.5%) |
Sep 2003 | - | $7.09B(-0.4%) |
Jun 2003 | - | $7.12B(-12.7%) |
Mar 2003 | - | $8.16B(-0.7%) |
Dec 2002 | $8.21B(+26.8%) | $8.21B(+19.0%) |
Sep 2002 | - | $6.90B(-3.7%) |
Jun 2002 | - | $7.16B(-0.9%) |
Mar 2002 | - | $7.23B(+11.6%) |
Dec 2001 | $6.48B(-6.1%) | $6.48B(+1.2%) |
Sep 2001 | - | $6.40B(+1.8%) |
Jun 2001 | - | $6.29B(-9.8%) |
Mar 2001 | - | $6.97B(+1.0%) |
Dec 2000 | $6.90B(-1.7%) | $6.90B(-4.5%) |
Sep 2000 | - | $7.22B(+6.2%) |
Jun 2000 | - | $6.80B(-1.3%) |
Mar 2000 | - | $6.89B(-1.9%) |
Dec 1999 | $7.02B(+24.2%) | $7.02B(+12.3%) |
Sep 1999 | - | $6.25B(+5.0%) |
Jun 1999 | - | $5.95B(+5.3%) |
Dec 1998 | $5.65B(+83.5%) | $5.65B(+75.2%) |
Jun 1998 | - | $3.23B(+4.7%) |
Dec 1997 | $3.08B(-3.8%) | $3.08B(-3.8%) |
Dec 1996 | $3.20B(+2.4%) | $3.20B(+2.4%) |
Dec 1995 | $3.13B(+5.5%) | $3.13B(+1.4%) |
Jun 1995 | - | $3.09B(+4.1%) |
Dec 1994 | $2.96B(-15.1%) | $2.96B(-15.1%) |
Dec 1993 | $3.49B(-12.0%) | $3.49B |
Dec 1992 | $3.97B(+129.3%) | - |
Dec 1991 | $1.73B(+7.1%) | - |
Dec 1990 | $1.62B | - |
FAQ
- What is AstraZeneca annual total current liabilities?
- What is the all time high annual current liabilities for AstraZeneca?
- What is AstraZeneca annual current liabilities year-on-year change?
- What is AstraZeneca quarterly total current liabilities?
- What is the all time high quarterly current liabilities for AstraZeneca?
- What is AstraZeneca quarterly current liabilities year-on-year change?
What is AstraZeneca annual total current liabilities?
The current annual current liabilities of AZN is $27.87B
What is the all time high annual current liabilities for AstraZeneca?
AstraZeneca all-time high annual total current liabilities is $30.54B
What is AstraZeneca annual current liabilities year-on-year change?
Over the past year, AZN annual total current liabilities has changed by -$2.68B (-8.76%)
What is AstraZeneca quarterly total current liabilities?
The current quarterly current liabilities of AZN is $29.13B
What is the all time high quarterly current liabilities for AstraZeneca?
AstraZeneca all-time high quarterly total current liabilities is $29.13B
What is AstraZeneca quarterly current liabilities year-on-year change?
Over the past year, AZN quarterly total current liabilities has changed by +$228.00M (+0.79%)